Jocelyn Gal
Centre Antoine Lacassagne(FR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Head and Neck Cancer Studies, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma(2017)598 cited
- → Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: Multicentric study of the GEC-ESTRO Breast Cancer Working Group(2013)154 cited
- → Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome(2014)110 cited
- → Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes(2012)104 cited
- → Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas(2015)100 cited
- → Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey(2021)93 cited
- → Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study(2018)85 cited
- → Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)(2014)69 cited
- → Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: Lessons from a systematic review of recent randomized trials(2011)68 cited
- → Long-term quality of life and psycho-social outcomes after oropharyngeal cancer surgery and radial forearm free-flap reconstruction: A GETTEC prospective multicentric study(2017)64 cited